Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02446857
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
1DA | 1-DEAZA-ADENOSINE | A | 1ADD | 0.79 |  |
FYA | ADENOSINE-5'-[PHENYLALANINOL-PHOSPHATE] | A,B | 2IY5 | 0.72 | |
| FYA | ADENOSINE-5'-[PHENYLALANINOL-PHOSPHATE] | A | 1B7Y | 0.72 | |
A3D | 3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE | A,B,C,D | 1PZG | 0.73 | |
| A3D | 3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE | A | 1DRV | 0.73 | |
| A3D | 3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE | A,B | 2EWD | 0.73 | |
| A3D | 3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE | A,B,C,D | 1PZF | 0.73 | |
AD3 | 3-DEAZA-ADENOSINE | A,B | 1KIE | 0.79 | |
| AD3 | 3-DEAZA-ADENOSINE | A,B,C,D | 2ZIZ | 0.79 | |
| AD3 | 3-DEAZA-ADENOSINE | A,B | 1R4F | 0.79 | |
| AD3 | 3-DEAZA-ADENOSINE | A,B | 1HP0 | 0.79 | |
IDD | (5R,6R,7S,8S)-5-(HYDROXYMETHYL)- 2-PHENYL-5,6,7,8-TETRAHYDROIMIDAZO[1,2- A]PYRIDINE-6,7,8-TRIOL | A | 1X38 | 0.78 | |
| IDD | (5R,6R,7S,8S)-5-(HYDROXYMETHYL)- 2-PHENYL-5,6,7,8-TETRAHYDROIMIDAZO[1,2- A]PYRIDINE-6,7,8-TRIOL | A | 1LQ2 | 0.78 | |
218 | 1-[(4-AMINO-2-METHYLPYRIMIDIN-5- YL)METHYL]-3-(2-HYDROXYETHYL)-2- METHYLPYRIDINIUM | A | 2HOP | 0.7 | |
3AA | 3-AMINOPYRIDINE-ADENINE DINUCLEOTIDE PHOSPHATE | A,B,E,F | 1F6M | 0.74 | |
475 | N-[oxo(pyridin-2-ylamino)acetyl]- beta-D-glucopyranosylamine | A | 3CUV | 0.71 | |
CNA | CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE | A,B | 1SZC | 0.7 | |
| CNA | CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE | A | 1A26 | 0.7 | |
| CNA | CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE | A,B | 2OD2 | 0.7 | |
3BK | (2R,3R,4S,5R)-2-[6-amino-8-[(3,4- dichlorophenyl)methylamino]purin- 9-yl]-5-(hydroxymethyl)oxolane- 3,4-diol | A | 3FZK | 0.78 | |
IDE | (5R,6R,7S,8S)-3-(ANILINOMETHYL)- 5,6,7,8-TETRAHYDRO-5-(HYDROXYMETHYL)- IMIDAZO[1,2-A]PYRIDINE-6,7,8-TRIOL | A | 1X39 | 0.72 | |
| IDE | (5R,6R,7S,8S)-3-(ANILINOMETHYL)- 5,6,7,8-TETRAHYDRO-5-(HYDROXYMETHYL)- IMIDAZO[1,2-A]PYRIDINE-6,7,8-TRIOL | A,B | 2J7C | 0.72 | |
5I5 | 7-(5-DEOXY-BETA-D-RIBOFURANOSYL)- 5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN- 4-AMINE | A,B,C,D | 2I6A | 0.74 | |
1RB | 1-ALPHA-D-RIBOFURANOSYL-BENZIMIAZOLE- 5'-PHOSPHATE | A | 1L5K | 0.75 | |
7DA | 7-DEAZA-2'-DEOXYADENOSINE-5'-MONOPHOSPHATE | B | 1U1K | 0.77 | |
DBI | PHOSPHORIC ACID MONO-[5-(5,6-DIMETHYL- BENZOIMIDAZOL-1-YL)-4-HYDROXY-2- HYDROXYMETHYL-TETRAHYDRO-FURAN- 3-YL] ESTER | A | 1ID8 | 0.76 | |
MBZ | 1-[2-DEOXYRIBOFURANOSYL]-4-METHYL- BENZOIMIDAZOLE-5'-MONOPHOSPHATE | 1,2 | 1EEK | 0.76 | |
5ID | (2R,3R,4S,5R)-2-(4-AMINO-5-IODO- 7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL)- 5-(HYDROXYMETHYL)TETRAHYDROFURAN- 3,4-DIOL | A,B | 2ZOQ | 0.76 | |
| 5ID | (2R,3R,4S,5R)-2-(4-AMINO-5-IODO- 7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL)- 5-(HYDROXYMETHYL)TETRAHYDROFURAN- 3,4-DIOL | A | 2VUW | 0.76 | |
| 5ID | (2R,3R,4S,5R)-2-(4-AMINO-5-IODO- 7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL)- 5-(HYDROXYMETHYL)TETRAHYDROFURAN- 3,4-DIOL | A,B,C,D | 2C47 | 0.76 | |
8ID | NICOTINAMIDE-8-IODO-ADENINE-DINUCLEOTIDE | A,B,C,D | 2HCY | 0.7 | |
3FD | 4-[[(2R,3S,4R,5R)-5-[6-amino-8- [(3,4-dichlorophenyl)methylamino]purin- 9-yl]-3,4-dihydroxy-oxolan-2-yl]methoxymethyl]benzonitrile | A | 3FZL | 0.71 | |
4MF | 1-(2-DEOXY-5-O-PHOSPHONO-BETA-D- ERYTHRO-PENTOFURANOSYL)-4-METHYL- 1H-INDOLE | C | 2OXM | 0.72 | |
| 4MF | 1-(2-DEOXY-5-O-PHOSPHONO-BETA-D- ERYTHRO-PENTOFURANOSYL)-4-METHYL- 1H-INDOLE | B,C | 2OYT | 0.72 | |